Overview

Cholera Anti-Secretory Treatment Trial

Status:
Completed

Trial end date:
2020-07-27

Target enrollment:

Participant gender:

Summary

This trial was designed to assess safety and preliminary efficacy of oral doses of iOWH032 on diarrhea output and clinical symptoms after a cholera challenge in healthy adult participants.

Phase:

Phase 2

Details

Lead Sponsor:

PATH

Collaborators:

Pharmaron
University of Maryland, Baltimore

Treatments:

Anti-Bacterial Agents